Lee, C. S., Chen, S., Berry, C. T., Kelly, A. R., Herman, P. J., Oh, S., O’Connor, R. S., Payne, A. S., & Ellebrecht, C. T. (2024). Fate induction in CD8 CAR T cells through asymmetric cell division. Nature, 633(8030), 670–677. https://doi.org/10.1038/s41586-024-07862-7

Ventin, M., Cattaneo, G., Arya, S., Jia, J., Gelmi, M. C., Sun, Y., Maggs, L., Ksander, B. R., Verdijk, R. M., Boland, G. M., Jenkins, R. W., Haq, R., Jager, M. J., Wang, X., Ryeom, S., & Ferrone, C. R. (2024). Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting. Clinical Cancer Research, 30(15), 3243–3258. https://doi.org/10.1158/1078-0432.ccr-24-0071

Vincent, R. L., Li, F., Ballister, E. R., Arpaia, N., & Danino, T. (2024). Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells. Journal of Visualized Experiments, 204. https://doi.org/10.3791/65887

Vincent, R. L., Gurbatri, C. R., Li, F., Vardoshvili, A., Coker, C., Im, J., Ballister, E. R., Rouanne, M., Savage, T., de los Santos-Alexis, K., Redenti, A., Brockmann, L., Komaranchath, M., Arpaia, N., & Danino, T. (2023). Probiotic-guided CAR-T cells for solid tumor targeting. Science, 382(6667), 211–218. https://doi.org/10.1126/science.add7034

McNerney, K. O., Si Lim, S. J., Ishikawa, K., Dreyzin, A., Vatsayan, A., Chen, J. J., Baggott, C., Prabhu, S., Pacenta, H. L., Philips, C., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Verneris, M., Myers, D., Karras, N. A., Brown, P., Bonifant, C. L., … Schultz, L. M. (2023). HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Advances, 7(12), 2758–2771. https://doi.org/10.1182/bloodadvances.2022008893

Wayne, A. S., Huynh, V., Hijiya, N., Rouce, R. H., Brown, P. A., Krueger, J., Kitko, C. L., Ziga, E. D., Hermiston, M. L., Richards, M. K., Baruchel, A., Schuberth, P. C., Rossi, J., Zhou, L., Goyal, L., Jain, R., Vezan, R., Masouleh, B. K., & Lee, D. W. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica, 108(3), 747–760. https://doi.org/10.3324/haematol.2022.280678

Moskop, A., Pommert, L., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Keating, A. K., … Schultz, L. M. (2022). Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood Advances, 6(14), 4251–4255. https://doi.org/10.1182/bloodadvances.2021006393

Vincent, R., & Danino, T. (2021). CAR-T cells SEAK help from enzymes. Nature Chemical Biology, 18(2), 122–123. https://doi.org/10.1038/s41589-021-00933-0